首页> 外文会议>International Congress on Coronary Artery Disease. >Plasma circulating endothelin-1 in on-pump coronary surgery cardiopulmonary bypass
【24h】

Plasma circulating endothelin-1 in on-pump coronary surgery cardiopulmonary bypass

机译:泵浦冠状动脉手术心肺旁路的等离子体循环内皮素-1

获取原文

摘要

Endotheline-1 (ET-1) is an endothelium-derived potent vasoconstrictor peptide of 21 amino acid residues. On-pump coronary surgery is realized with cardiopulmonary bypass (CPB) and initiates physiologic changes, which can induce ET-1 synthesis. The purpose of this study is to determine and compare the plasma ET-1values before and after CPB. Ten patients comprised 2 female and 8 male undergoing coronary artery bypass grafting are investigated, having CPB. EDTA-plasma samples are collected 10 minutes before the extracorporeal circulation (CPB), 1 hour and 2 hours postoperatively. ET-1 is extracted by acetone from 1 ml of plasma and subjected to a sensitive enzyme-linked immunosorbent assay. Plasma levels of ET-1 in the 10 subject before the CPB are 0.68 ± 0.11 fmol/ml (mean ± SD, n=10), ranging from 0.57 to 1 fmol/ml. At 1 hour CPB plasma ET-1 levels are 17 % and 39 % less in 1 male and 1 female patient respectively, as compared to Et-1 values before the operation. The same male and female patients showed 11 % and 33 % less ET-1 concentration respectively, after 24 hours from the operation. ET-1 concentration is significantly increased in only 1 male patient, by 20 % as compared to the base value. Pre- and postoperative plasma ET-1 concentrations are in the range of normal human subjects. The postoperative decrease of the ET-1 concentration in patients may be to its binding to ET receptors and thus reduce its circulating values. The increase of ET-1 level in one patient may be associated with endothelium injury.
机译:内皮曲-1(ET-1)是21个氨基酸残基的内皮衍生的有效血管电机肽。泵送冠状动脉外科与心肺旁路(CPB)实现,并启动生理变化,可以诱导ET-1合成。本研究的目的是在CPB之前和之后确定和比较血浆ET-1Values。 10名患者包含2名女性和8名男性接受冠状动脉旁路接枝,具有CPB。 EDTA-血浆样品在体外循环(CPB)之前10分钟收集,术后1小时和2小时。 ET-1通过丙酮从1mL等离子体中提取,并进行敏感的酶联免疫吸附测定。在CPB之前,在10个受试者中的血浆水平的ET-1为0.68±0.11 fmol / ml(平均值±Sd,n = 10),范围为0.57至1 fmol / ml。与操作前的ET-1值相比,在1小时内,CPB血浆ET-1水平分别为1次雄性和1名女性患者39%少39%。在手术中24小时后,相同的雄性和女性患者分别表现出11%和33%少的ET-1浓度。与基值相比,ET-1浓度仅为1名雄性患者显着增加20%。术后血浆ET-1浓度在正常人体受试者的范围内。患者ET-1浓度的术后降低可能是其与ET受体的结合,从而降低其循环值。一个患者ET-1水平的增加可能与内皮损伤有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号